Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Weight loss drugs benefit from a clear, measurable endpoint and a clinical infrastructure already oriented toward chronic metabolic disease
PLoS ONE 9:e103526
Jurewicz J, Radwan P, Wielgomas B, Radwan M, Karwacka A, Kaluzny P, et al
#Diabetes #PrecisionMedicine #Ferroptosis #HydrogenSulfide #MetabolicDisease #InnovationInMedicine #CellBiology #TranslationalResearch #HealthcareInnovation #ScientificDiscovery To view or add a comment, sign in For years, scientists thought they knew exactly how the worlds most popular diabetes drug worked, but it turns out they were looking at the wrong organ (Awkward)
US$ 26.39
US$ 23.42
US$ 28.99
US$ 29.67
US$ 25.09
US$ 29.10
US$ 25.72
US$ 22.20
